Patrick J. Nolan

Array ( [id] => 971863 [patent_doc_number] => 06936248 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-30 [patent_title] => 'Methods of inhibiting GPR-9-6 function' [patent_app_type] => utility [patent_app_number] => 09/522752 [patent_app_country] => US [patent_app_date] => 2000-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 75 [patent_no_of_words] => 27775 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/936/06936248.pdf [firstpage_image] =>[orig_patent_app_number] => 09522752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 668648 [patent_doc_number] => 07094890 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-22 [patent_title] => 'Arthritis-associated protein' [patent_app_type] => utility [patent_app_number] => 09/522699 [patent_app_country] => US [patent_app_date] => 2000-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 10867 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094890.pdf [firstpage_image] =>[orig_patent_app_number] => 09522699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1421867 [patent_doc_number] => 06515111 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Monoclonal antibody which inhibits transendothelial migration of human mononuclear leukocytes' [patent_app_type] => B1 [patent_app_number] => 09/508071 [patent_app_country] => US [patent_app_date] => 2000-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3471 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/515/06515111.pdf [firstpage_image] =>[orig_patent_app_number] => 09508071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7629738 [patent_doc_number] => 06818618 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-16 [patent_title] => 'Inhibition of smooth muscle cell migration by Tenascin-C peptides' [patent_app_type] => B1 [patent_app_number] => 09/519703 [patent_app_country] => US [patent_app_date] => 2000-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 10104 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/818/06818618.pdf [firstpage_image] =>[orig_patent_app_number] => 09519703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6128387 [patent_doc_number] => 20020076410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'PROCESSES FOR PRODUCTION OF IMMUNOGLOBULIN A IN MILK' [patent_app_type] => new [patent_app_number] => 09/424246 [patent_app_country] => US [patent_app_date] => 2000-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10067 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20020076410.pdf [firstpage_image] =>[orig_patent_app_number] => 09424246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1565228 [patent_doc_number] => 06376207 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Assay and reagents for quantifying hBNp' [patent_app_type] => B1 [patent_app_number] => 09/510721 [patent_app_country] => US [patent_app_date] => 2000-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9576 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376207.pdf [firstpage_image] =>[orig_patent_app_number] => 09510721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1179607 [patent_doc_number] => 06740512 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-25 [patent_title] => 'Neutral sphingomyelinase' [patent_app_type] => B1 [patent_app_number] => 09/485473 [patent_app_country] => US [patent_app_date] => 2000-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 4978 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/740/06740512.pdf [firstpage_image] =>[orig_patent_app_number] => 09485473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 935325 [patent_doc_number] => 06974674 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-12-13 [patent_title] => 'Predisposition to infection associated with intense exercise or other stress' [patent_app_type] => utility [patent_app_number] => 09/913297 [patent_app_country] => US [patent_app_date] => 2000-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6928 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/974/06974674.pdf [firstpage_image] =>[orig_patent_app_number] => 09913297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 760021 [patent_doc_number] => 07011835 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-03-14 [patent_title] => 'Targeted destruction of pests' [patent_app_type] => utility [patent_app_number] => 09/501912 [patent_app_country] => US [patent_app_date] => 2000-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 7141 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/011/07011835.pdf [firstpage_image] =>[orig_patent_app_number] => 09501912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6890430 [patent_doc_number] => 20010007661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-12 [patent_title] => 'Composition containing Alpha-fodrin or Alpha-fodrin fragment protein' [patent_app_type] => new-utility [patent_app_number] => 09/499765 [patent_app_country] => US [patent_app_date] => 2000-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8981 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20010007661.pdf [firstpage_image] =>[orig_patent_app_number] => 09499765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1234499 [patent_doc_number] => 06689361 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => 'SPE-4 antibody preparations' [patent_app_type] => B1 [patent_app_number] => 09/496239 [patent_app_country] => US [patent_app_date] => 2000-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8805 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689361.pdf [firstpage_image] =>[orig_patent_app_number] => 09496239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4265296 [patent_doc_number] => 06245334 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Method of causing selective immunosuppression using HL-60-related lectins' [patent_app_type] => 1 [patent_app_number] => 9/489292 [patent_app_country] => US [patent_app_date] => 2000-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 12986 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245334.pdf [firstpage_image] =>[orig_patent_app_number] => 489292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4266000 [patent_doc_number] => 06306660 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Method for improving the accuracy of the semi-quantitative determination of analyte in fluid samples' [patent_app_type] => 1 [patent_app_number] => 9/484293 [patent_app_country] => US [patent_app_date] => 2000-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4716 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306660.pdf [firstpage_image] =>[orig_patent_app_number] => 484293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1208330 [patent_doc_number] => 06713060 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Nek1-related protein kinase' [patent_app_type] => B1 [patent_app_number] => 09/481275 [patent_app_country] => US [patent_app_date] => 2000-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21280 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713060.pdf [firstpage_image] =>[orig_patent_app_number] => 09481275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1175265 [patent_doc_number] => 06743429 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-01 [patent_title] => 'Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases' [patent_app_type] => B2 [patent_app_number] => 09/475072 [patent_app_country] => US [patent_app_date] => 1999-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11782 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/743/06743429.pdf [firstpage_image] =>[orig_patent_app_number] => 09475072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4384988 [patent_doc_number] => 06277955 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Materials and method for the detection and treatment of Wegener\'s granulomatosis' [patent_app_type] => 1 [patent_app_number] => 9/472579 [patent_app_country] => US [patent_app_date] => 1999-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2086 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277955.pdf [firstpage_image] =>[orig_patent_app_number] => 472579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1304437 [patent_doc_number] => 06620914 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-16 [patent_title] => 'Transcription factor islet-brain 1 (IB1)' [patent_app_type] => B1 [patent_app_number] => 09/402214 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 24 [patent_no_of_words] => 29041 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/620/06620914.pdf [firstpage_image] =>[orig_patent_app_number] => 09402214 [rel_patent_id] =>[rel_patent_doc_number] =>)